Respiratory Disease Imaging Market Size (2022-2030) Share, Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports
Pune, Dec. 01, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Respiratory Disease Imaging Market By Type (X-Ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, and Nuclear Imaging), By Disease Indication (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, and Others) - Global Outlook & Forecast 2022-2030" published by Growth Plus Reports, the respiratory disease imaging market is expected to grow at a CAGR of 8.4% from 2021 to reach US$ 16.32 billion by 2030. Owing to the increasing prevalence of respiratory diseases globally.
Get a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/respiratory-disease-imaging-market/7992
Growth Drivers
The primary driver fueling the market's expansion is the increasing prevalence of respiratory disorders caused by rising air pollution levels. The market is being driven by the increase in air pollution and the discharge of dangerous gases that cause lung diseases like COPD and other respiratory illnesses all over the world. The spread of infections like tuberculosis and hospital-acquired infections, where these tests are used as a preliminary detection tool, are among the other factors causing the overall growth.
The global respiratory disease imaging market has been analyzed from three perspectives: type, disease indication, and region.
Excerpts from ‘By Type Segmentation’
Based on type, the global respiratory disease imaging market is subdivided into:
X-ray
Magnetic Resonance Imaging (Mri)
Computed Tomography (Ct) Scan
Nuclear Imaging
Others
The market for respiratory disease imaging worldwide is dominated by the X-ray segment. The category has expanded because of hospitals and diagnostic facilities use X-rays more frequently. X-rays are perfect for quick diagnosis and treatment plans because they are non-invasive, painless, and take less time. Chest x-ray demand is increasing due to the rise in chest illnesses. On the other hand, the increasing prevalence of COPD is likely to push the CT-scan segment in the upcoming years.
Excerpts from ‘By Region Segmentation’
Based on region, the global respiratory disease imaging market has been segmented into:
North America
Europe
Asia Pacific
Rest of the World
During the projected period, Asia Pacific is anticipated to grow at the fastest rate. This growth can be primarily attributed to expanding access to diagnostic procedures for patients and bettering the infrastructure of the healthcare system. Along with these additional factors, market players in the region are expected to increase their investments and drive market growth in Latin America and Asia Pacific as well as the rising prevalence of respiratory diseases.
Speak to our Analyst to Understand the Impact of COVID-19 on Your Business:
Excerpts from ‘Competitive Landscape’
The prominent players operating in the global respiratory disease imaging market are:
GE Healthcare
Polarean, Inc.
Koninklijke Philips N.V.
Siemens Healthineers
Canon Medical Systems Corp.
Mindray Medical International
Bruker
Hologic, Inc.
PerkinElmer Inc.
FUJIFILM VisualSonics Inc.
Table of Content
INTRODUCTION
Market Ecosystem
Timeline Under Consideration
Historical Years – 2020
Base Year – 2021
Forecasted Years – 2022 to 2030
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Data Collection Methodology
Data Sources
Secondary Sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecasting Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trends (COVID-19 Perspective)
Key Players & Competitive Positioning (2021)
MARKET DYNAMICS
Drivers
Restraints/Challenges
Opportunities
GLOBAL RESPIRATORY DISEASE IMAGING MARKET - ANALYSIS & FORECAST, BY TYPE
X-Ray
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT) Scan
Nuclear Imaging
Others
GLOBAL RESPIRATORY DISEASE IMAGING MARKET - ANALYSIS & FORECAST, BY DISEASE INDICATION
Chronic Obstructive Pulmonary Disease
Lung Cancer
Asthma
Tuberculosis
Others
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
Distributor Landscape Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players
Directly Purchase Premium Copy of Respiratory Disease Imaging Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=CA1MxrxwXGnDoq6l4SmpRJ0PKaf4rQBWt537ohND&report_id=7992&license=Single
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
CONTACT: Manan Sethi Director, Market Insights Email: enquire@growthplusreports.com Phone no: +91 96545 76783 Web: https://growthplusreports.com/ Follow Us: LinkedIn | Twitter